Karyopharm Therapeutics Inc.
KPTI
$8.38
-$0.17-1.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 63.74M | 45.88M | 51.70M | 69.94M | 108.71M |
| Total Receivables | 26.18M | 31.88M | 32.93M | 35.24M | 30.77M |
| Inventory | 4.04M | 3.97M | 4.99M | 4.77M | 4.74M |
| Prepaid Expenses | 9.19M | 8.03M | 8.25M | 10.29M | 12.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 103.15M | 89.75M | 97.87M | 120.24M | 156.46M |
|
|
|||||
| Total Current Assets | 103.15M | 89.75M | 97.87M | 120.24M | 156.46M |
| Net Property, Plant & Equipment | 4.65M | 4.80M | 5.33M | 5.80M | 6.28M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 618.00K | 1.68M | 1.68M | 1.67M | 1.67M |
| Total Assets | 108.42M | 96.23M | 104.88M | 127.71M | 164.42M |
|
|
|||||
| Total Accounts Payable | 4.00M | 5.39M | 2.60M | 5.87M | 5.11M |
| Total Accrued Expenses | 64.50M | 66.33M | 62.93M | 57.17M | 60.65M |
| Short-term Debt | -- | 250.00K | 24.48M | 24.46M | 24.43M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.98M | 13.42M | 7.63M | 927.00K | 438.00K |
| Total Finance Division Other Current Liabilities | 1.58M | 1.77M | 1.57M | 1.94M | 1.64M |
| Total Other Current Liabilities | 1.58M | 1.77M | 1.57M | 1.94M | 1.64M |
| Total Current Liabilities | 92.06M | 87.16M | 99.22M | 90.37M | 92.26M |
|
|
|||||
| Total Current Liabilities | 92.06M | 87.16M | 99.22M | 90.37M | 92.26M |
| Long-Term Debt | 278.22M | 250.24M | 225.75M | 228.33M | 236.45M |
| Short-term Debt | -- | 250.00K | 24.48M | 24.46M | 24.43M |
| Capital Leases | 5.74M | 6.01M | 6.25M | 6.49M | 6.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.32M | 22.08M | 12.59M | 8.41M | 15.01M |
| Total Liabilities | 401.34M | 365.49M | 343.81M | 333.60M | 350.44M |
|
|
|||||
| Common Stock & APIC | 1.47B | 1.39B | 1.39B | 1.38B | 1.38B |
| Retained Earnings | -1.76B | -1.66B | -1.62B | -1.59B | -1.56B |
| Treasury Stock & Other | 71.00K | -259.00K | -251.00K | -321.00K | -356.00K |
| Total Common Equity | -292.93M | -269.26M | -238.93M | -205.88M | -186.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -292.93M | -269.26M | -238.93M | -205.88M | -186.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -292.93M | -269.26M | -238.93M | -205.88M | -186.02M |
|
|
|||||